Transthyretin-derived peptides as β-amyloid inhibitors

ACS Chemical Neuroscience

Volumn 5, Issue 7, 2014, Pages 542-551

  Cho, Patricia Y ^a   Joshi, Gururaj ^b   Johnson, Jeffrey A ^b   Murphy, Regina M ^a  

^a University of Wisconsin Madison   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

aggregation; Alzheimer's; amyloid; beta amyloid; intrinsically disordered; peptide based drugs; transthyretin

Indexed keywords

AMYLOID BETA PROTEIN; EFH PEPTIDE; G12 PEPTIDE; GL16 PEPTIDE; GLA PEPTIDE; GSC PEPTIDE; PEPTIDE; PEPTIDOMIMETIC AGENT; PREALBUMIN; THIOFLAVINE; TRANSTHYRETIN DERIVED PEPTIDE; UNCLASSIFIED DRUG; AMYLOID BETA PROTEIN[1-40]; NEUROPROTECTIVE AGENT; PEPTIDE FRAGMENT; RECOMBINANT PROTEIN;

ARTICLE; BRAIN CELL CULTURE; CEREBROSPINAL FLUID; CROSS LINKING; DRUG PROTEIN BINDING; HYDROPHOBICITY; IN VITRO STUDY; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DEGRADATION; ANTAGONISTS AND INHIBITORS; BINDING SITE; CELL CULTURE; CHEMISTRY; CONFORMATION; DRUG EFFECTS; GENETICS; HUMAN; KINETICS; NERVE CELL; PHYSIOLOGY; PROTEIN SECONDARY STRUCTURE; RADIATION SCATTERING; SYNTHESIS; TRANSMISSION ELECTRON MICROSCOPY; TUNEL ASSAY;

AMYLOID BETA-PEPTIDES; BINDING SITES; CELLS, CULTURED; HUMANS; IN SITU NICK-END LABELING; KINETICS; MICROSCOPY, ELECTRON, TRANSMISSION; MOLECULAR CONFORMATION; NEURONS; NEUROPROTECTIVE AGENTS; PEPTIDE FRAGMENTS; PREALBUMIN; PROTEIN STRUCTURE, SECONDARY; PROTEOLYSIS; RECOMBINANT PROTEINS; SCATTERING, RADIATION;

EID: 84904414101     PISSN: None     EISSN: 19487193     Source Type: Journal    
DOI: 10.1021/cn500014u     Document Type: Article

References (59)

1. Hardy, J. and Selkoe, D. J. (2002) Medicine-The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics Science 297, 353-356 (Pubitemid 34790756)
2. Roychaudhuri, R., Yang, M., Hoshi, M. M., and Teplow, D. B. (2009) Amyloid beta-protein assembly and Alzheimer Disease J. Biol. Chem. 284, 4749-4753
3. Karran, E., Mercken, M., and De Strooper, B. (2011) The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics Nat. Rev. Drug Discovery 10, 698-U1600
4. Hawkes, C. A., Ng, V., and McLaurin, J. (2009) Small molecule inhibitors of Abeta aggregation and neurotoxicity Drug Dev. Res. 70, 111-124
5. Yang, F. S., Lim, G. P., Begum, A. N., Ubeda, O. J., Simmons, M. R., Ambegaokar, S. S., Chen, P. P., Kayed, R., Glabe, C. G., Frautschy, S. A., and Cole, G. M. (2005) Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo J. Biol. Chem. 280, 5892-5901 (Pubitemid 40280072)
6. Ehrnhoefer, D. E., Bieschke, J., Boeddrich, A., Herbst, M., Masino, L., Lurz, R., Engemann, S., Pastore, A., and Wanker, E. E. (2008) EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers Nat. Struct. Mol. Biol. 15, 558-566 (Pubitemid 351799141)
7. Feng, Y., Wang, X. P., Yang, S. G., Wang, Y. J., Zhang, X., Du, X. T., Sun, X. X., Zhao, M., Huang, L., and Liu, R. T. (2009) Resveratrol inhibits beta-amyloid oligomeric cytotoxicity but does not prevent oligomer formation Neurotoxicology 30, 986-995
8. Wong, H. E., Qi, W., Choi, H. M., Fernandez, E., and Kwon, I. (2011) A safe, blodd-brain barriar permeable triphenylmethane dye inhibits amyloid-beta neurotoxicity by generating nontoxic aggregates ACS Chem. Neurosci 2, 645-657
9. McLaurin, J., Golomb, R., Jurewicz, A., Antel, J. P., and Fraser, P. E. (2000) Inositol stereoisomers stabilize an oligomeric aggregate of Alzheimer amyloid beta peptide and inhibit A beta-induced toxicity J. Biol. Chem. 275, 18495-18502 (Pubitemid 30414810)
10. Gervais, F., Paquette, J., Morissette, C., Krzywkowski, P., Yu, M., Azzi, M., Lacombe, D., Kong, X. Q., Aman, A., Laurin, J., Szarek, W. A., and Tremblay, P. (2007) Targeting soluble A beta peptide with Tramiprosate for the treatment of brain amyloidosis Neurobiol. Aging 28, 537-547 (Pubitemid 46282205)
11. Craik, D. J., Fairlie, D. P., Liras, S., and Price, D. (2013) The future of peptide-based drugs Chem. Biol. Drug Des. 81, 136-147
12. McGregor, D. P. (2008) Discovering and improving novel peptide therapeutics Curr. Opin. Pharmacol. 8, 616-619
13. Hard, T. and Lendel, C. (2012) Inhibition of amyloid formation J. Mol. Biol. 421, 441-465
14. Sciarretta, K. L., Gordon, D. J., and Meredith, S. C. (2006) Peptide-based inhibitors of amyloid assembly Methods Enzymol. 413, 273-312 (Pubitemid 44528696)
15. Takahashi, T. and Mihara, H. (2008) Peptide and protein mimetics inhibiting amyloid beta-peptide aggregation Acc. Chem. Res. 41, 1309-1318
16. Tjernberg, L. O., Naslund, J., Lindqvist, F., Johansson, J., Karlstrom, A. R., Thyberg, J., Terenius, L., and Nordstedt, C. (1996) Arrest of beta-amyloid fibril formation by a pentapeptide ligand J. Biol. Chem. 271, 8545-8548 (Pubitemid 26123269)
17. Ghanta, J., Shen, C. L., Kiessling, L. L., and Murphy, R. M. (1996) A strategy for designing inhibitors of beta-amyloid toxicity J. Biol. Chem. 271, 29525-29528 (Pubitemid 26389569)
18. Taylor, M., Moore, S., Mayes, J., Parkin, E., Beeg, M., Canovi, M., Gobbi, M., Mann, D. M. A., and Allsop, D. (2010) Development of a proteolytically stable retro-inverso peptide inhibitor of beta-amyloid oligomerization as a potential novel treatment for Alzheimer's Disease Biochemistry 49, 3261-3272
19. Soto, C., Sigurdsson, E. M., Morelli, L., Kumar, R. A., Castano, E. M., and Frangione, B. (1998) Beta-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: Implications for Alzheimer's therapy Nat. Med. 4, 822-826 (Pubitemid 28331024)
20. Takahashi, T., Ohta, K., and Mihara, H. (2007) Embedding the amyloid beta-pepticle sequence in green fluorescent protein inhibits A beta oligomerization ChemBioChem 8, 985-988 (Pubitemid 47183614)
21. Perchiacca, J. M., Ladiwala, A. R. A., Bhattacharya, M., and Tessier, P. M. (2012) Structure-based design of conformation- and sequence-specific antibodies against amyloid beta Proc. Natl. Acad. Sci. U.S.A. 109, 84-89
22. Parthsarathy, V., McClean, P. L., Holscher, C., Taylor, M., Tinker, C., Jones, G., Kolosov, O., Salvati, E., Gregori, M., Masserini, M., and Allsop, D. (2013) A novel retro-inverso peptide inhibitor reduces amyloid deposition, oxidation and inflammation and stimulates neurogenesis in the APPswe/PS1 Delta E9 mouse model of Alzheimer's Disease PLoS One 8, e54769
23. Orner, B. P., Liu, L., Murphy, R. M., and Kiessling, L. L. (2006) Phage display affords peptides that modulate beta-amyloid aggregation J. Am. Chem. Soc. 128, 11882-11889 (Pubitemid 44360224)
24. Funke, S. A., van Groen, T., Kadish, I., Bartnik, D., Nagel-Steger, L., Brener, O., Sehl, T., Batra-Safferling, R., Moriscot, C., Schoehn, G., Horn, A. H. C., Muller-Schiffmann, A., Korth, C., Sticht, H., and Willbold, D. (2010) Oral treatment with the D-enantiomeric peptide D3 improves the pathology and behavior of Alzheimer's Disease transgenic mice ACS Chem. Neurosci. 1, 639-648
25. Acerra, N., Kad, N. M., and Mason, J. M. (2013) Combining intracellular selection with protein-fragment complementation to derive Abeta interacting peptides Protein Eng., Des. Sel. 26, 463-470
26. Luo, Y., Vali, S., Sun, S. Y., Chen, X. S., Liang, X., Drozhzhina, T., Popugaeva, E., and Bezprozvanny, I. (2013) Abeta 42-binding peptoids as amyloid aggregation inhibitors and detection ligands ACS Chem. Neurosci. 4, 952-962
27. Stein, T. D. and Johnson, J. A. (2002) Lack of neurodegeneration in transgenic mice overexpressing mutant amyloid precursor protein is associated with increased levels of transthyretin and the activation of cell survival pathways J. Neurosci. 22, 7380-7388 (Pubitemid 35386337)
28. Stein, T. D., Anders, N. J., DeCarli, C., Chan, S. L., Mattson, M. P., and Johnson, J. A. (2004) Neutralization of transthyretin reverses the neuroprotective effects of secreted amyloid precursor protein (APP) in APP(Sw) mice resulting in tau phosphorylation and loss of hippocampal neurons: Support for the amyloid hypothesis J. Neurosci. 24, 7707-7717 (Pubitemid 39186826)
29. Buxbaum, J. N., Ye, Z., Reixach, N., Friske, L., Levy, C., Das, P., Golde, T., Masliah, E., Roberts, A. R., and Bartfai, T. (2008) Transthyretin protects Alzheimer's mice from the behavioral and biochemical effects of Abeta toxicity Proc. Natl. Acad. Sci. U.S.A. 105, 2681-2686 (Pubitemid 351520573)
30. Giunta, S., Valli, M. B., Galeazzi, R., Fattoretti, P., Corder, E. H., and Galeazzi, L. (2005) Transthyretin inhibition of amylold beta aggregation and toxicity Clin. Biochem. 38, 1112-1119 (Pubitemid 41797752)
31. Costa, R., Goncalves, A., Saralva, M. J., and Cardoso, I. (2008) Transthyretin binding to ABeta peptide-Impact on ABeta fibrillogenesis and toxicity FEBS Lett. 582, 936-942
32. Li, X. Y., Masliah, E., Reixach, N., and Buxbaum, J. N. (2011) Neuronal production of transthyretin in human and murine Alzheimer's Disease: Is it protective? J. Neurosci. 31, 12483-12490
33. Yang, D. T., Joshi, G., Cho, P. Y., Johnson, J. A., and Murphy, R. M. (2013) Transthyretin as both a sensor and a scavenger of beta-amyloid oligomers Biochemistry 52, 2849-2861
34. Du, J. L. and Murphy, R. M. (2010) Characterization of the interaction of beta-amyloid with transthyretin monomers and tetramers Biochemistry 49, 8276-8289
35. Fandrich, M. (2012) Oligomeric intermediates in amyloid formation: Structure determination and mechanisms of toxicity J. Mol. Biol. 421, 427-440
36. Du, J. L., Cho, P. Y., Yang, D. T., and Murphy, R. M. (2012) Identification of beta-amyloid-binding sites on transthyretin Protein Eng., Des. Sel. 25, 337-345
37. Li, X. Y., Zhang, X., Ladiwala, A. R. A., Du, D. G., Yadav, J. K., Tessier, P. M., Wright, P. E., Kelly, J. W., and Buxbaum, J. N. (2013) Mechanisms of transthyretin inhibition of beta-amyloid aggregation in vitro J. Neurosci. 33, 19423-19433
38. Deng, W., Cao, A. N., and Lai, L. H. (2007) Detecting the inter-peptide arrangement and maturation process of transthyretin (105-115) amyloid fibril using a FRET pair with short Forster distance Biochem. Biophys. Res. Commun. 362, 689-694 (Pubitemid 47368147)
39. Jarvis, J. A., Kirkpatrick, A., and Craik, D. J. (1994) H-1-NMR analysis of fibril-forming peptide-fragments of transthyretin Int. J. Pept. Prot. Res. 44, 388-398
40. Gustavsson, A., Engstrom, U., and Westermark, P. (1991) Normal transthyretin and synthetic transthyretin fragments form amyloid-like fibrils in vitro Biochem. Biophys. Res. Commun. 175, 1159-1164
41. Fernandez-Escamilla, A. M., Rousseau, F., Schymkowitz, J., and Serrano, L. (2004) Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins Nat. Biotechnol. 22, 1302-1306 (Pubitemid 39336784)
42. Kyte, J. and Doolittle, R. F. (1982) A simple method for displaying the hydropathic character of a protein J. Mol. Biol. 157, 105-132
43. Fellouse, F. A., Wiesmann, C., and Sidhu, S. S. (2004) Synthetic antibodies from a four-amino-acid code: A dominant role for tyrosine in antigen recognition Proc. Natl. Acad. Sci. U.S.A. 101, 12467-12472 (Pubitemid 39122047)
44. Fellouse, F. A., Li, B., Compaan, D. M., Peden, A. A., Hymowitz, S. G., and Sidhu, S. S. (2005) Molecular recognition by a binary code J. Mol. Biol. 348, 1153-1162 (Pubitemid 40602373)
45. Koide, S. and Sidhu, S. S. (2009) The importance of being tyrosine: Lessons in molecular recognition from minimalist synthetic binding proteins ACS Chem. Biol. 4, 325-334
46. Bitan, G., Kirkitadze, M. D., Lomakin, A., Vollers, S. S., Benedek, G. B., and Teplow, D. B. (2003) Amyloid beta-protein (Abeta) assembly: Abeta 40 and Abeta 42 oligomerize through distinct pathways Proc. Natl. Acad. Sci. U.S.A. 100, 330-335 (Pubitemid 36078074)
47. Ladiwala, A. R. A., Litt, J., Kane, R. S., Aucoin, D. S., Smith, S. O., Ranjan, S., Davis, J., Van Nostrand, W. E., and Tessier, P. M. (2012) Conformational differences between two amyloid beta oligomers of similar size and dissimilar toxicity J. Biol. Chem. 287, 24765-24773
48. Jameson, L. P., Smith, N. W., and Dzyuba, S. V. (2012) Dye-binding assays for evaluation of the effects of small molecule inhibitors on amyloid (Abeta) self-assembly ACS Chem. Neurosci. 3, 807-819
49. Glabe, C. G. (2008) Structural classification of toxic amyloid oligomers J. Biol. Chem. 283, 29639-29643
50. Biancalana, M. and Koide, S. (2010) Molecular mechanism of Thioflavin-T binding to amyloid fibrils Biochim. Biophys. Acta, Proteins Proteomics 1804, 1405-1412
51. Jiang, X., Smith, C. S., Petrassi, H. M., Hammarstrom, P., White, J. T., Sacchettini, J. C., and Kelly, J. W. (2001) An engineered transthyretin monomer that is nonamyloidogenic, unless it is partially denatured Biochemistry 40, 11442-11452 (Pubitemid 32911287)
52. Jan, A., Adolfsson, O., Allaman, I., Buccarello, A. L., Magistretti, P. J., Pfeifer, A., Muhs, A., and Lashuel, H. A. (2011) Abeta 42 neurotoxicity is mediated by ongoing nucleated polymerization process rather than by discrete Abeta 42 species J. Biol. Chem. 286, 8585-8596
53. Selenica, M. L., Wang, X., Ostergaard-Pedersen, L., Westlind-Danielsson, A., and Grubb, A. (2007) Cystatin C reduces the in vitro formation of soluble Abeta 1-42 oligomers and protofibrils Scand. J. Clin. Lab. Invest. 67, 179-190 (Pubitemid 46410600)
54. Narayan, P., Orte, A., Clarke, R. W., Bolognesi, B., Hook, S., Ganzinger, K. A., Meehan, S., Wilson, M. R., Dobson, C. M., and Klenerman, D. (2012) The extracellular chaperone clusterin sequesters oligomeric forms of the amyloid-beta(1-40) peptide Nat. Struct. Mol. Biol. 19, 79-U97
55. Aldred, A. R., Brack, C. M., and Schreiber, G. (1995) The cerebral expression of plasma-protein genes in different species Comp. Biochem. Physiol., Part B: Biochem. Mol. Biol. 111, 1-15
56. Cascella, R., Conti, S., Mannini, B., Li, X. Y., Buxbaum, J. N., Tiribilli, B., Chiti, F., and Cecchi, C. (2013) Transthyretin suppresses the toxicity of oligomers formed by misfolded proteins in vitro Biochim. Biophys. Acta, Mol. Basis Dis. 1832, 2302-2314
57. Pallitto, M. M. and Murphy, R. M. (2001) A mathematical model of the kinetics of beta-amyloid fibril growth from the denatured state Biophys. J. 81, 1805-1822 (Pubitemid 32783616)
58. Fancy, D. A. and Kodadek, T. (1999) Chemistry for the analysis of protein-protein interactions: Rapid and efficient cross-linking triggered by long wavelength light Proc. Natl. Acad. Sci. U.S.A. 96, 6020-6024 (Pubitemid 29256612)
59. Bitan, G., Lomakin, A., and Teplow, D. B. (2001) Amyloid beta-protein oligomerization-Prenucleation interactions revealed by photo-induced cross-linking of unmodified proteins J. Biol. Chem. 276, 35176-35184